Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AktiengesellschaftfiledCriticalBayer Aktiengesellschaft
Priority to YU53596ApriorityCriticalpatent/YU53596A/en
Publication of YU53596ApublicationCriticalpatent/YU53596A/en
Pronalazak se odnosi na citostatike, koji su usled modifikovanja sa šećerom specifični za tumor. Pogodni razdeonik (spejser) obezbedjuje stabilnost seruma, a jednovremeno i intraćelijsko delovanje.The invention relates to cytostatics, which are tumor-specific by sugar modification. A convenient spacer ensures the stability of the serum and also the intracellular action.